OPK(OPKO Health, Inc.) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $1.77B | $1.00B | $863.50M | $713.14M | $606.88M |
| 毛利润 | — | $288.22M | $318.13M | $218.51M | $205.94M |
| 营业利润 | $18.75M | −$226.25M | −$157.02M | −$152.06M | −$117.41M |
| 净利润 | −$30.14M | −$328.40M | −$188.86M | −$53.22M | −$225.68M |
| 经营现金流 | $38.34M | −$95.19M | −$28.20M | −$183.49M | −$178.54M |
| 自由现金流 | $6.18M | −$119.77M | −$44.47M | −$208.50M | −$190.82M |
| 摊薄每股收益 | $-0.05 | $-0.46 | $-0.25 | $-0.08 | $-0.30 |